We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
1. Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS) have a high mortality rate and require prompt identification and management.
2. Fluid resuscitation is often the most important therapeutic intervention in both groups, and patients with HHS often need no exogenous insulin at all.
3. The high mortality rate often results from electrolyte disturbances, particularly hypokalaemia in DKA. It should be very closely monitored, particularly in the early phase of treatment.
4. Thromboembolism is a life-threatening complication in both groups of patients, so always consider thromboprophylaxis early.
5. Look for common precipitating factors in all patients, but be aware that the white cell count and amylase, sodium and creatinine levels can all be abnormal in otherwise uncomplicated diabetic emergencies.
Hyperosmolar hyperglycaemic state (HHS), usually seen in uncontrolled type 2 diabetics, is a life-threatening emergency with a mortality rate 10 times higher than that of DKA. This chapter provides key prescribing information on combating its primary features – dehydration, hyperglycaemia and increased thromboembolic risk.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.